Status:
UNKNOWN
Does Chemotherapy Train the Mutation of the Pig-A Gene? (PIGA)
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The PIG-A gene (in humans)/Pig-a (in rodents) may be a useful reporter of acquired gene mutation. A simple and reproductive test based on flow cytometry allows detection of Pig-a mutants in a few minu...
Eligibility Criteria
Inclusion
- Major patients
- Patients with breast cancer
- Who have benefited from breast surgical treatment and have a poly-chemotherapy adjuvanted by FEC100 and Docetaxel.
- Patients should be able to read and understand French.
Exclusion
- Minor Patients
- Pregnant women
- Patients who do not speak French and/or are unable to read and understand French.
- Patients who have had a history of radiotherapy, including those who have received a per-operative radiation therapy as part of the initial management of breast cancer
- Patients who have had a history of chemotherapy outside of the chemotherapy possibly received in the treatment of current breast cancer.
Key Trial Info
Start Date :
January 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 10 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03837054
Start Date
January 10 2019
End Date
January 10 2021
Last Update
February 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
: Service de Gynécologie Obstétrique Hôpital Nord
Marseille, Marseille Cedex 20, France, 13915